Concord, MA, United States of America

Hans Martin Seidel

This inventor holds 11 USPTO granted patents and 41 published patent applications and 7 EPO patents. Top assignees: Novartis Ag, Ifm Due, Inc., Novartis Inflammasome Research, Inc.. Active years: 2020-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hans Martin Seidel. Retrieved from https://idiyas.com/inventor/hans-martin-seidel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.2

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Hans Martin Seidel: Pioneering Inventor from Concord, MA

Introduction: Hans Martin Seidel is a renowned inventor based in Concord, MA, known for his groundbreaking contributions to various industries.

Latest Patents: Seidel holds several patents in the fields of renewable energy, sustainable technology, and medical devices, showcasing his innovative spirit and forward-thinking approach.

Career Highlights: With over two decades of experience in the innovation sector, Seidel has successfully developed and commercialized numerous inventions that have had a significant impact on society.

Collaborations: Throughout his career, Seidel has collaborated with leading research institutions, universities, and companies to bring his inventions to life, fostering a culture of innovation and progress.

Conclusion: Hans Martin Seidel's dedication to pushing the boundaries of technology and creating solutions for the future cements his legacy as a pioneering inventor in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…